TrialAdvances in therapy2021

Roxadustat for the Maintenance Treatment of Anemia in Patients with End-Stage Kidney Disease on Stable Dialysis: A European Phase 3, Randomized, Open-Label, Active-Controlled Study (PYRENEES).

Botond Csiky et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.